🔎 Trials Near Me

Hjem › Amyloidose › New York

Kliniske studier for Amyloidose i New York

10 studier for Amyloidose søker deltakere på steder i New York.

Byer i New York

Offisiell studietekst (engelsk)

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

  • Icahn School of Medicine at Mt. Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05652335

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

  • Research Site, Manhasset
  • Research Site, New York
  • Research Site, New York
  • og 1 flere
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06465810

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Manhasset
  • Clinical Trial Site, New York
  • Clinical Trial Site, New York
  • og 2 flere
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07052903

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  • Clinical Trial Site, New York
  • Clinical Trial Site, New York
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07223203

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

  • Clinical Trial Site, New York
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT04561518

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

  • Columbia University Medical Center, New York
RekruttererObservasjonsstudie
Alder 30 til 80 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT05489549

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • New York University (NYU) School of Medicine - Langone Medical Center, New York
  • Mount Sinai Hospital, New York
  • Columbia University Medical Center, New York
  • og 1 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

  • Research Site, New York
  • Research Site, New York
  • Research Site, New York
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT07081646

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

  • Icahn School of Medicine at Mount Sinai /ID# 255408, New York
  • Columbia University Medical Center /ID# 255068, New York
  • Memorial Sloan Kettering Cancer Center-Koch Center /ID# 255073, New York
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT06158854

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • New York University (NYU) School of Medicine - Langone Medical Center, New York
  • Columbia University Medical Center, New York
RekruttererFase 3
Alder 18 til 90 · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06128629

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.